SEC Comment Letter for BiomX Inc. (PHGE) (CIK 0001739174) (HLSQ) — Sep 19, 2019

BiomX Inc. (PHGE) (CIK 0001739174)
Date: Sept. 19, 2019 · CIK: 0001739174 · Accession: 0000000000-19-013778

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-38762

Date

September 19, 2019

Author

Jonas Grossman

Form

UPLOAD

Company

BiomX Inc. (PHGE) (CIK 0001739174)

Letter

September 19, 2019 Jonas Grossman Chief Executive Officer Chardan Healthcare Acquisition Corp. 17 State Street, 21st Floor New York, NY 10004 Re:Chardan Healthcare Acquisition Corp. Preliminary Proxy Statement on Schedule 14A Filed July 17, 2019 File No. 001-38762 Dear Mr. Grossman: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance cc: Giovanni Caruso

Show Raw Text

September 19, 2019
Jonas Grossman
Chief Executive Officer
Chardan Healthcare Acquisition Corp.
17 State Street, 21st Floor
New York, NY 10004
Re:Chardan Healthcare Acquisition Corp.
Preliminary Proxy Statement on Schedule 14A
Filed July 17, 2019
File No. 001-38762
Dear Mr. Grossman:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance
cc:       Giovanni Caruso

SecProbe.io